National Research Foundation   Report issue

Foundation Phase 3
Founded: Pretoria South Africa (1998)

Organization Overview

First Clinical Trial
2014
NCT03332069
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

National Research Foundation of South Africa

Active Ingredients

Drugs in Phase 3 Trials (1)

cisplatin (platinol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fever (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1